MNOV
Income statement / Annual
Last year (2024), MediciNova, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2024, MediciNova, Inc.'s net income was -$11.05 M.
See MediciNova, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$1.00 M |
$0.00 |
$4.04 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$23.94 K
|
$25.88 K
|
$28.10 K
|
$14.13 K
|
$26.70 K
|
| Gross Profit |
$0.00
|
$1.00 M
|
$0.00
|
$4.04 M
|
$0.00
|
-$23.94 K
|
-$25.88 K
|
-$28.10 K
|
-$14.13 K
|
-$26.70 K
|
| Gross Profit Ratio |
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$7.20 M
|
$5.66 M
|
$9.14 M
|
$8.10 M
|
$7.49 M
|
$6.08 M
|
$5.63 M
|
$4.22 M
|
$3.52 M
|
$3.02 M
|
| General & Administrative Expenses |
$5.22 M
|
$4.98 M
|
$5.24 M
|
$5.49 M
|
$6.45 M
|
$7.95 M
|
$9.96 M
|
$8.80 M
|
$7.36 M
|
$5.81 M
|
| Selling & Marketing Expenses |
$258.65 K
|
$257.93 K
|
$248.61 K
|
$228.78 K
|
$240.47 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$5.48 M
|
$5.24 M
|
$5.48 M
|
$5.72 M
|
$6.69 M
|
$7.95 M
|
$9.96 M
|
$8.80 M
|
$7.36 M
|
$5.81 M
|
| Other Expenses |
-$413.00
|
-$400.00
|
$388.00
|
$438.00 K
|
-$357.00
|
-$46.16 K
|
-$22.89 K
|
$120.21 K
|
$20.06 K
|
-$14.82 K
|
| Operating Expenses |
$12.68 M
|
$10.90 M
|
$14.63 M
|
$14.25 M
|
$14.18 M
|
$14.03 M
|
$15.59 M
|
$13.03 M
|
$10.88 M
|
$8.82 M
|
| Cost And Expenses |
$12.68 M
|
$10.90 M
|
$14.63 M
|
$14.25 M
|
$14.18 M
|
$14.03 M
|
$15.59 M
|
$13.03 M
|
$10.88 M
|
$8.82 M
|
| Interest Income |
$1.67 M
|
$1.83 M
|
$809.67 K
|
$143.63 K
|
$361.18 K
|
$1.15 M
|
$939.91 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$298.00
|
$454.00
|
$514.00
|
| Depreciation & Amortization |
$21.08 K
|
$20.30 K
|
$17.71 K
|
$26.15 K
|
$21.34 K
|
$23.94 K
|
$25.88 K
|
$28.10 K
|
$14.13 K
|
$26.70 K
|
| EBITDA |
-$12.65 M |
-$9.88 M |
-$14.61 M |
-$10.19 M |
-$14.16 M |
-$14.01 M |
-$15.56 M |
-$13.00 M |
-$10.87 M |
-$8.80 M |
| EBITDA Ratio |
0
|
-9.88
|
0
|
-2.52
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
-9.9
|
0
|
-2.53
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.63 M
|
$1.33 M
|
$562.39 K
|
$84.13 K
|
$322.78 K
|
$1.10 M
|
$917.02 K
|
$119.91 K
|
$19.61 K
|
-$15.33 K
|
| Income Before Tax |
-$11.04 M
|
-$8.57 M
|
-$14.07 M
|
-$10.13 M
|
-$13.86 M
|
-$12.93 M
|
-$14.67 M
|
-$12.91 M
|
-$10.86 M
|
-$8.84 M
|
| Income Before Tax Ratio |
0
|
-8.57
|
0
|
-2.51
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$5.54 K
|
$3.05 K
|
$2.82 K
|
$2.57 K
|
-$1.65 K
|
$12.66 K
|
$5.28 K
|
-$1.74 M
|
$3.75 K
|
$7.36 K
|
| Net Income |
-$11.05 M
|
-$8.57 M
|
-$14.07 M
|
-$10.13 M
|
-$13.85 M
|
-$12.94 M
|
-$14.68 M
|
-$11.16 M
|
-$10.87 M
|
-$8.85 M
|
| Net Income Ratio |
0
|
-8.57
|
0
|
-2.51
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.23 |
-0.17 |
-0.29 |
-0.21 |
-0.31 |
-0.3 |
-0.36 |
-0.32 |
-0.33 |
-0.33 |
| EPS Diluted |
-0.23 |
-0.17 |
-0.29 |
-0.21 |
-0.31 |
-0.3 |
-0.36 |
-0.32 |
-0.33 |
-0.33 |
| Weighted Average Shares Out |
$49.05 M
|
$49.05 M
|
$49.05 M
|
$48.60 M
|
$44.41 M
|
$43.16 M
|
$41.12 M
|
$35.14 M
|
$32.99 M
|
$26.58 M
|
| Weighted Average Shares Out Diluted |
$49.05 M
|
$49.05 M
|
$49.05 M
|
$48.60 M
|
$44.41 M
|
$43.16 M
|
$41.12 M
|
$35.14 M
|
$32.99 M
|
$26.58 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
